JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $206,000 | +139.5% | 24,611 | +111.9% | 0.03% | +130.8% |
| Q3 2021 | $86,000 | +4.9% | 11,616 | -3.7% | 0.01% | +8.3% |
| Q2 2021 | $82,000 | -34.4% | 12,067 | -0.8% | 0.01% | -45.5% |
| Q1 2021 | $125,000 | +47.1% | 12,159 | 0.0% | 0.02% | +46.7% |
| Q4 2020 | $85,000 | -19.0% | 12,159 | -5.1% | 0.02% | -34.8% |
| Q3 2020 | $105,000 | +20.7% | 12,816 | +1.3% | 0.02% | +9.5% |
| Q2 2020 | $87,000 | – | 12,656 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |